# FDA recall D-107-2013

> **Abbott Laboratories** · Class II · drug recall initiated 2012-12-04.

## Product

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

## Reason for recall

Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.

## Distribution

US Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-107-2013
- **Recalling firm:** Abbott Laboratories
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-12-04
- **Report date:** 2013-01-09
- **Termination date:** 2015-07-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Abbott Park, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-107-2013

## Citation

> AI Analytics. FDA recall D-107-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-107-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*